Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Understanding of Genetics by Men at Risk for Prostate Cancer

Mayo Clinic · with National Cancer Institute (NCI) · NCT04550845

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 40–95 · Men only
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
90
US sites recruiting
3
Study start
May 1, 2023
Record last updated
November 6, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

With this greater certainty regarding prognosis, men with localized prostate cancer are now equipped with make better treatment planning decisions. This study is designed to investigate the understanding of prognostic genetic technology in African American and rural White men at risk for localized prostate cancer.

Being studied: Focus group analyses

Conditions: Prostate Cancer

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • African-American or White men
  • Living in a rural or urban areas
  • Age 40 to 95 years old
  • Able and willing to provide informed consent
  • English-speaking
  • Willing to participate in the study.

This study will use the United States Department of Agriculture Office of Rural Development's definition of rural, which is as a city or town that has a population less than 50,000 inhabitants to define rural.

This study will use the United States Census Bureau's definition of urban, which is a city or town that has a population greater than 50,000 inhabitants to define urban.

Exclusion Criteria

Women will be excluded from participating in this study. However, women will be recruited to serve on an advisory panel to review the video-based educational tool for the comprehension of genomic terminology for prognostic genetic testing in patients with localized prostate cancer.

Recruiting US locations

  • Mayo Clinic

    Phoenix, AZ 85054

    Site contact: Clinical Trials Referral Office · 855-776-0015 · mayocliniccancerstudies@mayo.edu

  • Mayo Clinic in Florida

    Jacksonville, FL 32224-9980

    Site contact: Clinical Trials Referral Office · 855-776-0015 · mayocliniccancerstudies@mayo.edu

  • Mayo Clinic

    Rochester, MN 55905

    Site contact: Clinical Trials Referral Office · 855-776-0015 · mayocliniccancerstudies@mayo.edu

Study contacts (from the official record)

  • Ewan K Cobran, PhD · 480-301-6392 · cobran.ewan@mayo.edu
All healthy volunteers studies in Arizona →
Understanding of Genetics by Men at Risk for Prostate Cancer (NCT04550845) | Bored Studies